Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06059170

Enrollment

187

Registered

2023-09-28

Start date

2017-03-17

Completion date

2018-12-31

Last updated

2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Anterior Resection Syndrome, Rectal Cancer

Brief summary

Quality of life and risk factors for developing major LARS are explored. Therapeutic options were explored in the cohort experiencing major LARS

Detailed description

Quality of life and risk factors for developing major LARS are explored using the EORTC QLQ C30. Therapeutic options were explored in the cohort experiencing major LARS

Interventions

BEHAVIORALLARS score/ EORTC QLQ C30

administering questionnaire

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Intervention model description

cross sectional study

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* low anterior resection for rectal cancer between 2006-2016 * Adults

Exclusion criteria

* abdomino perineal resection * patients who do not understand Dutch

Design outcomes

Primary

Measure	Time frame	Description
Assessment QoL	up to 10 years after rectal resection	Assessments using questionnaire European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ C30)
frequencies of therapeutic options to manage LARS	up to 10 years after rectal resection	Self developed questionaire to determine what therapeutic options were used to manage LARS
Frequency of LARS	up to 10 years after rectal resection	Assessment of LARS using validated LARS Score

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026